Tapewire

NYSE · USD

JNJ

JOHNSON & JOHNSON

Export transactions ↓
Tapewire entity
2722
SEC CIK
0000200406
Parsed reports
1,771

Last 12 months

Inside the activity.

1 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202602
Feb 2026015
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202607
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 12, 2019 Filed Dec 16, 2019 22:40 UTC
Wengel Kathryn EEVP, Chief GSC Officer
Exercise / conversionCommon Stock 2,017 $62.62 $126,304.54
Disclosure

SEC source: 0001225208-19-015859 · doc4.xml · nonDerivative · entry 1

Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,736.2521

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 10, 2019 Filed Dec 12, 2019 23:05 UTC GrantDeferred Share Units · Derivative 349.415 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-015729 · doc4.xml · derivative · entry 1

Washington A. Eugene · CIK 0001561989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,425.0333

Underlying: Common Stock · 349.415 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
September 11, 2019 Filed Feb 13, 2020 21:10 UTC GiftCommon Stock 2,692 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-002167 · doc4.xml · nonDerivative · entry 1

PEREZ WILLIAM D · CIK 0001184649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,530

Read SEC document
September 10, 2019 Filed Sep 11, 2019 20:11 UTC GrantDeferred Share Units · Derivative 382.388 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012323 · doc4.xml · derivative · entry 1

Washington A. Eugene · CIK 0001561989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,075.6183

Underlying: Common Stock · 382.388 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
June 11, 2019 Filed Jun 11, 2019 21:01 UTC PurchaseCommon Stock 3,000 $139.68 $419,040.00
Disclosure

SEC source: 0001225208-19-009128 · doc4.xml · nonDerivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Read SEC document
June 11, 2019 Filed Jun 12, 2019 21:10 UTC GrantDeferred Share Units · Derivative 349.616 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009184 · doc4.xml · derivative · entry 1

Washington A. Eugene · CIK 0001561989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,693.2303

Underlying: Common Stock · 349.616 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
May 07, 2019 Filed Feb 12, 2020 23:47 UTC
Ullmann Michael HExec VP, General Counsel
GiftCommon Stock 353 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-002102 · doc4.xml · nonDerivative · entry 2

Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,370.882

F1 · shares: Gift

Read SEC document
March 12, 2019 Filed Mar 13, 2019 16:46 UTC GrantDeferred Share Units · Derivative 340.632 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-005181 · doc4.xml · derivative · entry 1

Washington A. Eugene · CIK 0001561989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,343.6143

Underlying: Common Stock · 340.632 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 28, 2019 Filed Feb 12, 2020 23:47 UTC
Ullmann Michael HExec VP, General Counsel
GiftCommon Stock 736 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-002102 · doc4.xml · nonDerivative · entry 1

Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,723.882

F1 · shares: Gift

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:14 UTC GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002391 · doc4.xml · derivative · entry 1

Beckerle Mary C · CIK 0001520181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,222.439

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:55 UTC GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002417 · doc4.xml · derivative · entry 1

DAVIS D SCOTT · CIK 0001227733 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,921.888

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:55 UTC GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002418 · doc4.xml · derivative · entry 1

PRINCE CHARLES · CIK 0001225179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,576.898

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:55 UTC GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002419 · doc4.xml · derivative · entry 1

PEREZ WILLIAM D · CIK 0001184649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,254.418

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:55 UTC GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002420 · doc4.xml · derivative · entry 1

Washington A. Eugene · CIK 0001561989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,002.9823

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:55 UTC GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002421 · doc4.xml · derivative · entry 1

WILLIAMS RONALD A · CIK 0001185243 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,360.73

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:55 UTC GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002422 · doc4.xml · derivative · entry 1

MULCAHY ANNE M · CIK 0001201725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,007.189

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:55 UTC GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002423 · doc4.xml · derivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,884.291

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:55 UTC GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002424 · doc4.xml · derivative · entry 1

Doudna Jennifer A · CIK 0001739090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,402

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 12, 2019 Filed Feb 13, 2019 19:55 UTC
Davis IanDirector
GrantDeferred Share Units · Derivative 1,402 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002425 · doc4.xml · derivative · entry 1

Davis Ian · CIK 0001494009 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,007.189

Underlying: Common Stock · 1,402 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Duato JoaquinVice Chair, Exec Committee
GrantRestricted Share Units · Derivative 5,424 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 10

Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,424

Underlying: Common Stock · 5,424 shares

Expires not disclosed

F8 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

F8 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Duato JoaquinVice Chair, Exec Committee
Exercise / conversionPerformance Share Units · Derivative 22,624 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 9

Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,624 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Duato JoaquinVice Chair, Exec Committee
GrantEmployee Stock Options (Right to Buy) · Derivative 110,868 $0.00 Strike: $131.94 $0.00
Disclosure

SEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 8

Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,868

Underlying: Common Stock · 110,868 shares

Expires 2029-02-11

F7 · security: Awarded under Issuer's Long-Term Incentive Plan.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Duato JoaquinVice Chair, Exec Committee
Tax withholdingCommon Stock 11,435 $131.94 $1,508,733.90
Disclosure

SEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 5

Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,705

F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Duato JoaquinVice Chair, Exec Committee
GrantCommon Stock 3,710 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 4

Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,140

F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Duato JoaquinVice Chair, Exec Committee
Exercise / conversionCommon Stock 22,624 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 3

Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,430

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Gorsky AlexDirector · Chairman, CEO
GrantRestricted Share Units · Derivative 11,129 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002348 · doc4.xml · derivative · entry 13

Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,129

Underlying: Common Stock · 11,129 shares

Expires not disclosed

F10 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

F10 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Gorsky AlexDirector · Chairman, CEO
Exercise / conversionPerformance Share Units · Derivative 73,947 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002348 · doc4.xml · derivative · entry 12

Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 73,947 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

F4 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Gorsky AlexDirector · Chairman, CEO
GrantEmployee Stock Options (Right to Buy) · Derivative 227,464 $0.00 Strike: $131.94 $0.00
Disclosure

SEC source: 0001225208-19-002348 · doc4.xml · derivative · entry 11

Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,464

Underlying: Common Stock · 227,464 shares

Expires 2029-02-11

F9 · security: Awarded under Issuer's Long-Term Incentive Plan.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Gorsky AlexDirector · Chairman, CEO
Tax withholdingCommon Stock 37,374 $131.94 $4,931,125.56
Disclosure

SEC source: 0001225208-19-002348 · doc4.xml · nonDerivative · entry 7

Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389,456

F6 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Gorsky AlexDirector · Chairman, CEO
GrantCommon Stock 12,127 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002348 · doc4.xml · nonDerivative · entry 6

Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,830

F5 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Gorsky AlexDirector · Chairman, CEO
Exercise / conversionCommon Stock 73,947 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002348 · doc4.xml · nonDerivative · entry 5

Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414,703

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
GrantRestricted Share Units · Derivative 2,885 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002349 · doc4.xml · derivative · entry 11

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,885

Underlying: Common Stock · 2,885 shares

Expires not disclosed

F10 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

F10 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
Exercise / conversionPerformance Share Units · Derivative 7,541 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002349 · doc4.xml · derivative · entry 10

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,541 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
GrantEmployee Stock Options (Right to Buy) · Derivative 58,972 $0.00 Strike: $131.94 $0.00
Disclosure

SEC source: 0001225208-19-002349 · doc4.xml · derivative · entry 9

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,972

Underlying: Common Stock · 58,972 shares

Expires 2029-02-11

F9 · security: Awarded under Issuer's Long-Term Incentive Plan.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
Tax withholdingCommon Stock 3,578 $131.94 $472,081.32
Disclosure

SEC source: 0001225208-19-002349 · doc4.xml · nonDerivative · entry 5

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,468.4243

F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
GrantCommon Stock 1,237 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002349 · doc4.xml · nonDerivative · entry 4

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,046.4243

F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
Exercise / conversionCommon Stock 7,541 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002349 · doc4.xml · nonDerivative · entry 3

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,809.4243

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Mesquita Jorge S.Exec VP, WW Chair, Consumer
Exercise / conversionPerformance Share Units · Derivative 16,968 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002350 · doc4.xml · derivative · entry 7

Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,968 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Mesquita Jorge S.Exec VP, WW Chair, Consumer
Tax withholdingCommon Stock 11,577 $131.94 $1,527,469.38
Disclosure

SEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 5

Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,344

F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Mesquita Jorge S.Exec VP, WW Chair, Consumer
GrantCommon Stock 2,783 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 4

Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,921

F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Mesquita Jorge S.Exec VP, WW Chair, Consumer
Exercise / conversionCommon Stock 16,968 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 3

Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,138

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Sneed Michael EEVP, Global Corp Aff & COO
GrantRestricted Share Units · Derivative 1,517 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002351 · doc4.xml · derivative · entry 11

Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,517

Underlying: Common Stock · 1,517 shares

Expires not disclosed

F9 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

F9 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Sneed Michael EEVP, Global Corp Aff & COO
Exercise / conversionPerformance Share Units · Derivative 7,275 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002351 · doc4.xml · derivative · entry 10

Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,275 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Sneed Michael EEVP, Global Corp Aff & COO
GrantEmployee Stock Options (Right to Buy) · Derivative 31,003 $0.00 Strike: $131.94 $0.00
Disclosure

SEC source: 0001225208-19-002351 · doc4.xml · derivative · entry 9

Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,003

Underlying: Common Stock · 31,003 shares

Expires 2029-02-11

F8 · security: Awarded under Issuer's Long-Term Incentive Plan.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Sneed Michael EEVP, Global Corp Aff & COO
Tax withholdingCommon Stock 3,497 $131.94 $461,394.18
Disclosure

SEC source: 0001225208-19-002351 · doc4.xml · nonDerivative · entry 5

Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,383

F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Sneed Michael EEVP, Global Corp Aff & COO
GrantCommon Stock 1,193 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002351 · doc4.xml · nonDerivative · entry 4

Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,880

F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:14 UTC
Sneed Michael EEVP, Global Corp Aff & COO
Exercise / conversionCommon Stock 7,275 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002351 · doc4.xml · nonDerivative · entry 3

Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,687

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:15 UTC
Stoffels PaulusVice Chair, Exec Committee
GrantRestricted Share Units · Derivative 5,606 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 9

Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,606

Underlying: Common Stock · 5,606 shares

Expires not disclosed

F7 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

F7 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:15 UTC
Stoffels PaulusVice Chair, Exec Committee
Exercise / conversionPerformance Share Units · Derivative 31,428 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 8

Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31,428 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

Read SEC document
February 11, 2019 Filed Feb 13, 2019 02:15 UTC
Stoffels PaulusVice Chair, Exec Committee
GrantEmployee Stock Options (Right to Buy) · Derivative 114,575 $0.00 Strike: $131.94 $0.00
Disclosure

SEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 7

Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,575

Underlying: Common Stock · 114,575 shares

Expires 2029-02-11

F6 · security: Awarded under Issuer's Long-Term Incentive Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.